SCOTTSDALE, AZ / ACCESSWIRE / November 23, 2024 / Dr. Elisa Song, MD, is an integrative pediatrician, pediatric functional medicine expert, and mom to two thriving children - and she is on a mission ...

Robust Profitability amidst Consumption Mix-shiftAdjusted Net Income Grew 2.0% to RMB2.4 Billion Parcel Volume Increased 15.9% to 8.7 Billion SHANGHAI, Nov. 19, ...

Analytic Partners Placed Highest for Ability to Execute and Furthest for Completeness of Vision MIAMI, Nov. 22, 2024 ...

BATAVIA, Ill., Nov. 22, 2024 (GLOBE NEWSWIRE) -- High Wire Networks, Inc. (OTCQB: HWNI), a leading global provider of managed cybersecurity, reported results for continuing operations for the three ...

NEWPORT BEACH, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Elevai Labs, Inc. (NASDAQ: ELAB) ("Elevai" or the "Company"), a leader in medical aesthetics, announced today that it is has withdrawn the ...

Elevai Labs Inc. (NASDAQ: ELAB) (Elevai" or the "Company") announced today it will implement a 1-for-200 reverse stock split ("Reverse Stock Split") ...

NI Holdings, Inc. (the "Company", NASDAQ: NODK) announced today the appointment of Seth C. Daggett as President and Chief Executive Officer (CEO), effective ...

VANCOUVER, BC / ACCESSWIRE / November 22, 2024 / Kidoz Inc. (TSXV:KIDZ) (the "Company"), mobile AdTech developer and owner of the market-leading Kidoz Contextual Ad ...

A 523-gene oncology panel identifies actionable tumor variations and improves outcomes Originally published on Illumina News Center A large, multiyear study conducted by Illumina, Providence, and ...

STAMFORD, CT / ACCESSWIRE / November 22, 2024 / HARMANOriginally published on HARMAN NewsroomWe are excited to share that HARMAN has been recognized with the Silver Award for Responsible Investor of t ...

CRANFORD, N.J., Nov. 22, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) announced today that it will be executing a reverse stock split of its ...

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment ...